U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H12O6
Molecular Weight 300.2629
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIOSMETIN

SMILES

COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O)C=C3O

InChI

InChIKey=MBNGWHIJMBWFHU-UHFFFAOYSA-N
InChI=1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3

HIDE SMILES / InChI

Molecular Formula C16H12O6
Molecular Weight 300.2629
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Diosmetin is the aglycone of the flavonoid glycoside diosmin, which occurs naturally in citrus fruits. Diosmetin is found in the legume Acacia farnesiana Wild and Olea europaea L. leaves. Diosmin is hydrolyzed to its aglycone diosmetin by intestinal microflora enzymes before its absorption into the body. Pharmacologically, diosmetin is reported to exhibit anticancer, antimicrobial, antioxidant, oestrogenic and anti-inflammatory activities. Diosmetin increased inhibitory GSK-3beta phosphorylation, while selectively reducing gamma-secretase activity, Abetta generation, tau hyperphosphorylation and pro-inflammatory activation of microglia in vitro, without altering Notch processing. Therefore, diosmetin could be considered as potential candidate for novel anti- Alzheimer's disease therapy. Diosmetin is ER-beta agonist and potential novel drug for the acute myeloid leukemia treatment.

Originator

Sources: DOI: 10.1002/hlca.19250080179

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements.
2002 May
Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action.
2003 May 1
The beta-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2.
2003 Nov
Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102.
2003 Sep 9
Analysis and quantification of flavonoidic compounds from Portuguese olive (Olea europaea L.) leaf cultivars.
2005 Feb
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.
2005 Feb 15
In vitro antioxidant activity of some Teucrium species (Lamiaceae).
2005 Jun
Flavonoid glycosides in bergamot juice (Citrus bergamia Risso).
2006 May 31
Anti-proliferative and antioxidant constituents from Tecoma stans.
2006 Nov-Dec
Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship.
2006 Oct 16
Complete assignments of NMR data of 13 hydroxymethoxyflavones.
2007 Dec
A new flavone glycoside from the fruits of Luffa cylindrica.
2007 Dec
Pensteminoside, an unusual catalpol-type iridoid from Penstemon gentianoides HBK (Plantaginaceae).
2007 Jul
Effect of flavonoids on rat splenocytes, a structure-activity relationship study.
2008 Aug 15
Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation.
2008 Feb
New features on the fragmentation and differentiation of C-glycosidic flavone isomers by positive electrospray ionization and triple quadrupole mass spectrometry.
2008 Jun
Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
2008 Jun
A new ferulic acid ester and other constituents from Dracocephalum peregrinum.
2008 Oct
[Studies on chemical components of Lobelia chinensis].
2009 Feb
Ecdysteroids and a sucrose phenylpropanoid ester from Froelichia floridana.
2009 Feb
Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic reduction of diosmetin to hesperetin.
2009 Feb
Stimulatory constituents of Eclipta prostrata on mouse osteoblast differentiation.
2009 Jan
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.
2009 Jan 8
Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.
2009 Jun
The phytochemical analysis and antioxidant activity assessment of orange peel (Citrus sinensis) cultivated in Greece-Crete indicates a new commercial source of hesperidin.
2009 Mar
Cytotoxic activity of flavonoids from the flowers of Chrysanthemum morifolium on human colon cancer Colon205 cells.
2009 Sep
[Chemical constituents of Lobelia chinensis].
2009 Sep
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro.
2010
Effects of Various Flavonoids on the α-Synuclein Fibrillation Process.
2010 Jan 28
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents.
2010 Jun
Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study.
2010 Mar 11
Managing phenol contents in crop plants by phytochemical farming and breeding-visions and constraints.
2010 Mar 2
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
2011 May 1
In vitro effects of some flavones on human pyruvate kinase isoenzyme M2.
2015 Mar
Patents

Sample Use Guides

Mice: 50mg /kg/every other day for 6 weeks
Route of Administration: Intraperitoneal
Diosmetin caused G1 arrest at 10 microM in MDA-MB 468 cells after 48-h treatment whereas this effect was not observed in MCF-10A cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:33:37 GMT 2023
Edited
by admin
on Fri Dec 15 17:33:37 GMT 2023
Record UNII
TWZ37241OT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIOSMETIN
INCI   MI   WHO-DD  
INCI  
Official Name English
4'-METHYLLUTEOLIN
Common Name English
4H-1-BENZOPYRAN-4-ONE, 5,7-DIHYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-
Systematic Name English
3',5,7-TRIHYDROXY-4'-METHOXYFLAVONE
Systematic Name English
DIOSMETIN [INCI]
Common Name English
DIOSMETIN [MI]
Common Name English
5,7-DIHYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)CHROMEN-4-ONE
Systematic Name English
DIOSMETINE
Common Name English
LUTEOLIN-4'-METHYL ETHER
Common Name English
CYANIDENON-4'-METHYL ETHER 1479
Common Name English
DIOSMETOL
Common Name English
Diosmetin [WHO-DD]
Common Name English
5,7-DIHYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE
Systematic Name English
FLAVONE, 3',5,7-TRIHYDROXY-4'-METHOXY-
Systematic Name English
Classification Tree Code System Code
DSLD 4156 (Number of products:7)
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
Code System Code Type Description
EVMPD
SUB35834
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
HSDB
8101
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
WIKIPEDIA
DIOSMETIN
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
EPA CompTox
DTXSID80199966
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
DAILYMED
TWZ37241OT
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
SMS_ID
100000128590
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
PUBCHEM
5281612
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
CHEBI
4630
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
RXCUI
1314347
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY RxNorm
CAS
520-34-3
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
FDA UNII
TWZ37241OT
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
DRUG CENTRAL
4601
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
ECHA (EC/EINECS)
208-291-8
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
MERCK INDEX
m4594
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY Merck Index
MESH
C039602
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
DRUG BANK
DB11259
Created by admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
Related Record Type Details
PARENT -> IMPURITY
NMT 3%
USP
Related Record Type Details
ACTIVE MOIETY